We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Manual Defibrillators Outperform AEDs in Animal Study

By HospiMedica staff writers
Posted on 05 Nov 2003
A study that compared automated external defibrillation (AED) with manual defibrillation in a swine model to treat prolonged out-of-hospital ventricular fibrillation found that the AED's longer interval to first compression resulted in a poorer outcome. More...
The study was published in the October 2003 issue of the Annals of Emergency Medicine.

The objective of the study was to determine whether the delays in chest compressions and defibrillation associated with an AED would adversely affect outcome when compared with manual defibrillation. After eight minutes of untreated ventricular fibrillation, 16 swine were randomly assigned to AED defibrillation or manual defibrillation with the same biphasic truncated exponential waveform 150-J shock through the same type of pads. The primary outcome measure was 24-hour survival with good neurologic outcome. Although none of the animals in the AED group survived 24 hours, five of the eight animals in the manual defibrillation group survived 24 hours, all with good neurologic outcome.

The time interval from simulated defibrillator arrival to first compressions was 98 (plus or minus 18) seconds in the AED group versus 68 (plus or minus 15) seconds in the manual group. In particular, the interval from first shock to first chest compressions was 46 (plus or minus 18) seconds versus 22 (plus or minus 16) seconds, respectively. Thus, the mean percentage of time that chest compressions were performed in the first minute after the first countershock was 15% (plus or minus 13%) versus 40% (plus or minus 15%), respectively. The return of spontaneous circulation within five minutes of simulated defibrillator arrival occurred in only one of eight animals in the AED group versus six of eight animals in the manual group. The study was conducted by researchers at the University of Arizona (Tucson, USA), led by Robert A. Berg, M.D., department of pediatrics.




Related Links:
Univ. of Arizona

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.